Skip to main content
. 2013 Jul;59(1-2):19–26. doi: 10.1016/j.vph.2013.05.002

Fig. 1.

Fig. 1

Detection of anti-ICAM-1 antibodies in serum from SSc patients. Levels of anti-ICAM-1 IgG and IgM antibodies were measured in serum from 60 patients with scleroderma (n = 32 LSSc, n = 28 DSSc) and from 26 healthy controls, using immobilised recombinant human ICAM-1 as the capture antigen. *p < 0.05; **p < 0.01, Mann–Whitney tests compared to healthy controls.